Literature DB >> 8180201

Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.

K A Watson1, E P Mitchell, L N Johnson, J C Son, C J Bichard, M G Orchard, G W Fleet, N G Oikonomakos, D D Leonidas, M Kontou.   

Abstract

alpha-D-Glucose is a weak inhibitor of glycogen phosphorylase b (Ki = 1.7 mM) and acts as a physiological regulator of hepatic glycogen metabolism. Glucose binds to phosphorylase at the catalytic site and results in a conformational change that stabilizes the inactive T state of the enzyme, promoting the action of protein phosphatase 1 and stimulating glycogen synthase. It has been suggested that, in the liver, glucose analogues with greater affinity for glycogen phosphorylase may result in a more effective regulatory agent. Several alpha- and beta-anhydroglucoheptonic acid derivatives and 1-deoxy-1-thio-beta-D-glucose analogues have been synthesized and tested in a series of crystallographic and kinetic binding studies with glycogen phosphorylase. The structural results of the bound enzyme-ligand complexes have been analyzed, together with the resulting affinities, in an effort to understand and exploit the molecular interactions that might give rise to a better inhibitor. This work has shown the following: (i) Similar affinities may be obtained through different sets of interactions. Specifically, in the case of the alpha- and beta-glucose-C-amides, similar Ki's (0.37 and 0.44 mM, respectively) are obtained with the alpha-anomer through interactions from the ligand via water molecules to the protein and with the beta-anomer through direct interaction from the ligand to the protein. Thus, hydrogen bonds through water can contribute binding energy similar to that of hydrogen bonds directly to the protein. (ii) Attempts to improve the inhibition by additional groups did not always lead to the expected result. The addition of nonpolar groups to the alpha-carboxamide resulted in a change in conformation of the pyranose ring from a chair to a skew boat and the consequent loss of favorable hydrogen bonds and increase in the Ki. (iii) The addition of polar groups to the alpha-carboxamide led to compounds with the chair conformation, and in the examples studied, it appears that hydration by a water molecule may provide sufficient stabilization to retain the chair conformation. (iv) The best inhibitor was N-methyl-beta-glucose-C-carboxamide (Ki = 0.16 mM), which showed a 46-fold improvement in Ki from the parent beta-D-glucose. The decrease in Ki may be accounted for by a single hydrogen bond from the amide nitrogen to a main-chain carbonyl oxygen, an increase in entropy through displacement of a water molecule, and favorable van der Waals contacts between the methyl substituent and nonpolar protein residues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180201     DOI: 10.1021/bi00185a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.

Authors:  K E Tsitsanou; N G Oikonomakos; S E Zographos; V T Skamnaki; M Gregoriou; K A Watson; L N Johnson; G W Fleet
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  1999-05       Impact factor: 3.686

3.  Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

4.  Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes.

Authors:  Alpeshkumar K Malde; Alan E Mark
Journal:  J Comput Aided Mol Des       Date:  2010-11-04       Impact factor: 3.686

Review 5.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 6.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

7.  The how and why of protein-carbohydrate interaction: a primer to the theoretical concept and a guide to application in drug design.

Authors:  H J Gabius
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

8.  Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

Authors:  W H Martin; D J Hoover; S J Armento; I A Stock; R K McPherson; D E Danley; R W Stevenson; E J Barrett; J L Treadway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

9.  The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.

Authors:  M Gregoriou; M E Noble; K A Watson; E F Garman; T M Krulle; C de la Fuente; G W Fleet; N G Oikonomakos; L N Johnson
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

10.  Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.

Authors:  Evangelia D Chrysina; Magda N Kosmopoulou; Constantinos Tiraidis; Rozina Kardakaris; Nicolas Bischler; Demetres D Leonidas; Zsuzsa Hadady; Laszlo Somsak; Tibor Docsa; Pal Gergely; Nikos G Oikonomakos
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.